Using the metastatic process of ovarian cancer as the basis for our experimental work, we have shown in 3 ovarian cancer cell lines that INC280 treatment reduces or abrogates pertinent cell behaviours including motility and adhesion, using HGF stimulation to mimic the presence of HGF in ascites in ovarian cancer patients17, 45. Here, HGF is linked to ovarian cancer.